SHOW NOTES - EPISODE 118

Episode Summary: This groundbreaking episode examines how GLP-1 drugs like Ozempic are fundamentally transforming club dining, from kitchen economics to social dynamics, and explores innovative solutions for clubs facing this pharmaceutical revolution.

Key Topics Covered:

The scope of GLP-1 drug adoption among members
Collapsing kitchen economics with 30-40% reduced consumption
Social dining crisis and member discomfort
Design modifications for new dining realities
Innovative programming and pricing solutions
Future implications for club F&B programs

The Numbers That Matter:

15-20% of affluent Americans currently using GLP-1 drugs
30-40% projected adoption within 3 years
35% average check decline reported by clubs
70% reduction in individual food consumption
60% food waste in traditional prep models
20% of F&B revenue shifting to takeout

Economic Impacts:

Traditional cost structure (30-35% food, 40-45% labor) unsustainable
Average per-cover loss: $12 for GLP-1 users
Buffet model economics completely broken
Catering guarantees no longer reliable
Beverage programs facing reduced tolerance issues

Design Adaptations:

Physical Modifications:

Smaller plate sizes (7-inch vs 12-inch)
Flexible table systems
"Jewelry box" buffet presentations
Adjustable atmospheric lighting
Smaller kitchen prep areas
Precision cooking equipment for tiny portions

Service Model Changes:

Tapas-style flexible timing
"Collections" menu format
Experience-focused presentations
Tableside theater emphasis
Parallel wellness/traditional programs

Innovative Solutions:

Experience fees vs food charges
Membership-inclusive dining credits
Sophisticated mocktail programs
Zero-proof wine pairings
Educational programming emphasis
Expanded takeout operations

Social Dynamics:

"Eaters" vs "non-eaters" divide
Generational tensions over pharmaceutical use
Celebration challenges with non-eating guests
Wine culture crisis
Business dining confusion
Staff morale impacts

Future Implications:

Oral GLP-1 drugs will increase adoption
Dining rooms becoming "social galleries"
Staffing shift to nutrition specialists
Technology for mass customization
Fundamental questioning of F&B role

Immediate Action Items:

Anonymous member survey on GLP-1 usage
F&B vulnerability audit
Small-plate program pilot
Alternative pricing model exploration
Staff training on pharmaceutical impacts
Menu engineering for variety over volume

Design Recommendations:

Invest in smaller serviceware
Create flexible dining spaces
Develop "social lounges" vs formal dining
Plan kitchens for variety not volume
Design for experience over consumption
Enable multiple service models simultaneously

Key Insights: "We're not just feeding bodies anymore - we're nourishing communities in entirely new ways."

"The successful clubs will recognize dining as social theater where food is prop, not purpose."

"This isn't a trend to weather - it's a fundamental shift in human behavior driven by pharmaceutical intervention."

Warning Signs to Monitor:

Declining average checks
Increased food waste
Member complaints about portions
Staff morale issues
Event attendance dropping
Bar liability incidents

Connect With Us:

Website: golfclubhousedesign.com
LinkedIn: linkedin.com/in...

The Ozempic Impact - Designing for Dramatically Different Dining